The impact of left ventricular assist device implantation on physical activity levels in patients with chronic heart failure

Royal Perth Hospital0 sites30 target enrollmentMarch 5, 2014

Overview

No summary available.

Registry

who.int

Start Date

March 5, 2014

End Date

TBD

Last Updated

6 years ago

Study Type

Observational

Sex

All

Sponsor

•Intervention group will have a confirmed history of NYHA functional class III/IV heart failure symptoms (where class III heart failure symptoms is characterised by shortness of breath during low level of activity and class IV heart failure symptoms is characterised by shortness of breath at rest), have been clinically stable on left ventricular assist device for at least 3 months and will be an outpatient. The control group will have NYHA functional class III/IV heart failure symptoms and will be taking routine heart failure management pharmaceutical therapy.

•Participants with co\-morbidities that may influence the ability to undertake physical activity (eg. severe renal, pulmonary or hepatic dysfunction, active uncontrolled systemic infection, several mitral or aortic valve insufficiency and severe musculoskeletal disease will be excluded from the study. Participants who receive a cardiac transplant during the physical assessment period will be withdrawn from the study.